The old saying “if at first you don’t succeed, try, try again” is clearly evident with supporters of the Genomics and Personalized Medicine Act (GPMA). Rep. Anna Eshoo (D-CA) is working to introduce a fifth incarnation of the bill, details of which can be found here. She is trying to succeed where then Illinois senator Barack Obama and others have failed to get their versions of the GPMA legislation past committees. Rep. Eshoo is promising to reintroduce the bill in Congress by 2012, and President Obama would likely support a revived GPMA. A Congress eye-deep in budget wars, though, may not be as generous with tax credits and other funding as biotech advocates might want. What do you think are Rep. Eshoo’s chances of succeeding?

Poll Question:
Will Rep. Anna Eshoo (D-CA) succeed in formalizing the GPMA despite the failure of four previous legislative attempts?




Previous articleOGT and Abcodia to Leverage Prospective Biobank for Pancreatic Cancer Diagnostics
Next articleAblynx Gets €20M from Merck Serono to Expand Collaboration Into Osteoarthritis